Several genes have been associated with dilated cardiomyopathy (DCM), a condition conferring risk of heart failure and sudden death. Among these is RNA-binding motif protein 20 (RBM20), with mutations present in ∼3% of individuals with DCM. Guo et al. now characterise a spontaneous rat model that explains how defects in RBM20 function can cause cardiomyopathy and provides insight into normal regulation of heart function. The mutant rats were known to have impaired splicing of titin, a sarcomeric protein that confers structure and function to striated muscle. Guo et al. determined that RBM20 is required for titin splicing, as well as for alternative splicing of many other conserved cardiac genes, as revealed by deep sequencing of rat and human samples. Defective splicing caused by Rbm20 mutation in rats results in features resembling those of humans carrying RBM20 mutations, including left ventricular dilatation, subendocardial fibrosis, arrhythmia and sudden death. These data explain how RBM20 mutations cause disease in a subset of individuals with DCM, and identify RBM20 as a global regulator of heart function by controlling the alternative splicing of specific cardiac genes.
Cardiomyopathy: RBM20 mutations impair splicing of cardiac genes Open Access
Cardiomyopathy: RBM20 mutations impair splicing of cardiac genes. Dis Model Mech 1 May 2012; 5 (3): 287. doi:
Download citation file:
Advertisement
Cited by
The Company of Biologists Workshops

For the last 15 years, our publisher, The Company of Biologists, has provided an apt environment to inspire biology and support biologists through our Workshops series. Read about the evolution of the Workshop series and revisit JEB's experience with hosting the first Global South Workshop.
A new perspective on disease research
DMM publishes perspectives – peer-reviewed articles that provide expert analysis of a topic important to the disease research community. Read our collection from authors presenting new or potentially controversial ideas or hypotheses, to help address future challenges and forge new directions.
Read & Publish Open Access publishing: what authors say

We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Fast & Fair peer review

Our sister journal Biology Open has recently launched the next phase of their Fast & Fair peer review initiative: offering high-quality peer review within 7 working days. To learn more about BiO’s progress and future plans, read the Editorial by Daniel Gorelick, or visit the Fast & Fair peer review page.
Interviews with Biologists @ 100 conference speakers

Explore our interviews with keynote speakers from the Biologists @ 100 conference, hosted to celebrate our publisher’s 100th anniversary, where we discuss climate change and biodiversity with Hans-Otto Pörtner and Jane Francis, health and disease with Charles Swanton and Sadaf Farooqi, and emerging technologies with Manu Prakash and Jennifer Lippincott-Schwartz.
Other journals from
The Company of Biologists